Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Adjuvant chemotherapy for older patients with stage II/III gastric cancer: A retrospective cohort study.
Authors
Yu-Hsuan Shih
Taichung Veterans General Hospital, Taichung, Taiwan;
Yu-Hsuan Shih , Hsin-Chen Lin , Chiann-Yi Hsu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 303)
DOI
10.1200/JCO.2023.41.4_suppl.303
Abstract #
303
Poster Bd #
C2
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical significance of time interval between surgery and adjuvant chemotherapy in patients with gastric cancer after gastrectomy: A population-based cohort study using a nationwide claims database.
First Author: Chi Hoon Maeng
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prospective cohort study of patients with stage III colorectal cancer aged ≥ 80 years who underwent curative resection: The HiSCO-04 study.
First Author: Manabu Shimomura Sr.
Poster
2014 Gastrointestinal Cancers Symposium
Adjuvant chemotherapy for elderly patients (age 70 or older) with gastric cancer after gastrectomy with D2 dissection: A single-center experience.
First Author: Jae-Cheol Jo
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Impact of previous adjuvant oxaliplatin combination therapy on survival in elderly colorectal cancer patients with recurrence.
First Author: Yusuke Nagata